This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_LIPOSARCOMA_EXALLC for full statistics.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
247 |
4. Check minimum number of eventsNone |
247 |
5. Include endpointsNone |
247 |
6. Filter based on genotype QC (FinnGen only) |
247 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Liposarcoma
based on the number of shared cases.
Similar with more cases:
- Liposarcoma, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 247 | 90 | 157 |
| Unadjusted period prevalence (%) | 0.06 | 0.03 | 0.07 |
| Median age at first event (years) | 62.22 | 59.38 | 63.85 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 216
- Matched controls
- 2159
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C49.22
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including hip liposarcoma
838.4
65.5
61
*
8850/3-C49.2
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
53.4
49
*
C48.02
ICD-10 Finland
Malignant tumor of the retroperitoneal space liposarcoma
641.1
52.8
50
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
42.4
46.2
57
18
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
45.4
42
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
467.9
40.5
39
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
438.7
38.3
37
*
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
159.9
27.3
28
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
29.9
23.4
31
12
8850/3-C49.6
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
23.3
22
*
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
23.3
22
*
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
134.2
23.1
24
*
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
89.6
22.2
24
*
D17.2
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
27.7
21.5
29
12
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
7.7
20.8
51
83
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.0
20.2
145
732
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.7
20.1
45
63
8850/3-C49.1
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
20.1
19
*
C49.42
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen liposarcoma
+∞
18.0
17
*
C49.12
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder liposarcoma
+∞
18.0
17
*
8858/3-C48.0
ICD-O-3
Dedifferentiated liposarcoma of retroperitoneum
+∞
18.0
17
*
ZXE10
NOMESCO Finland
More than one and less than three hours
3.6
17.4
121
568
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
24.3
17.3
24
11
B01AB05
ATC
enoxaparin; parenteral
3.6
16.8
104
444
WF001
NOMESCO Finland
Preoperative radiotherapy
28.8
15.9
21
8
B01AB10
ATC
tinzaparin; parenteral
7.0
15.6
40
68
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
15.5
95
394
WX402
NOMESCO Finland
General anaesthesia
4.2
15.0
65
202
8850/3-C48.0
ICD-O-3
Liposarcoma, NOS, of retroperitoneum
+∞
14.7
14
*
130
Kela drug reimbursment
Malignant tumour
5.0
14.5
50
123
C49.2
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of lower limb, including hip
+∞
13.7
13
*
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
10.3
12.9
25
27
R4110
NOMESCO Finland
Physiotherapy
3.1
12.8
89
394
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
74.3
12.7
14
*
JN4BD
NOMESCO Finland
Extensive body CT
4.1
12.7
54
162
ZXD10
NOMESCO Finland
Scheduled procedure
2.9
12.1
113
599
8850/3-C49.4
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
11.6
11
*
C49.10
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder without histology
+∞
11.6
11
*
C49.32
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax liposarcoma
+∞
11.6
11
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
7.0
11.0
27
43
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.1
10.9
35
79
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
22.9
10.8
15
7
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.8
10.6
30
58
KAC00
NOMESCO Finland
Nephrectomy
115.3
10.5
11
*
C49.52
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis liposarcoma
+∞
10.5
10
*
8852/3-C49.2
ICD-O-3
Myxoid liposarcoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
10.5
10
*
C48.0
ICD-10 Finland
Malignant neoplasm: Retroperitoneum
+∞
10.5
10
*
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
8.6
10.4
22
28
A04AA02
ATC
granisetron; systemic, transdermal
5.2
10.0
31
67
ZXE20
NOMESCO Finland
More than three and less than five hours
3.3
10.0
55
202
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
57.6
9.7
11
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.9
9.7
32
74
C48.09
ICD-10 Finland
Malignant tumor of the retroperitoneal space other or unspecified tumor
104.4
9.5
10
*
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
11.4
9.5
17
16
R4120
NOMESCO Finland
Occupational therapy
4.8
9.3
31
73
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
10.7
9.2
17
17
KAC10
NOMESCO Finland
Total nephrectomy with capsule
16.5
9.2
14
9
TPH07
NOMESCO Finland
Cathetrisation of artery
3.6
9.1
43
140
XX3DW
NOMESCO Finland
Time consuming IT work
3.6
9.0
43
141
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
10.7
8.7
16
16
JN4AD
NOMESCO Finland
Body CT examination
4.2
8.6
33
89
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
93.5
8.5
9
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.4
8.5
42
142
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
8.4
8
*
C49.62
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the trunk, unspecified localization liposarcoma
+∞
8.4
8
*
H02AB02
ATC
dexamethasone; systemic
3.6
8.3
39
126
ZXA05
NOMESCO Finland
Left side
2.5
8.3
77
388
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
13.7
8.0
13
10
D17.9
ICD-10 Finland
Benign lipomatous neoplasm, unspecified
13.7
8.0
13
10
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.4
8.0
89
491
S18
ICPC
Laceration/cut
2.3
7.9
109
661
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
6.6
7.7
19
31
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
4.4
7.6
27
68
C49.02
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck liposarcoma
82.8
7.5
8
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
11.4
7.4
13
12
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
7.8
7.3
16
22
8851/3-C49.2
ICD-O-3
Liposarcoma, well differentiated, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
7.3
7
*
N02BE01
ATC
paracetamol; systemic, rectal
3.0
7.3
192
1576
JAH00
NOMESCO Finland
Laparotomy
8.4
7.2
15
19
ZXA00
NOMESCO Finland
Right side
2.4
7.2
74
385
NBR20
NOMESCO Finland
Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm
31.1
7.2
9
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.9
7.0
22
49
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
7.6
6.8
15
21
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.6
6.8
15
21
ZXE00
NOMESCO Finland
One hour or less
2.2
6.8
98
597
L03AA14
ATC
lipegfilgrastim; parenteral
10.5
6.6
12
12
Z3226
NOMESCO Finland
Physiotherapist
2.5
6.5
54
251
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.5
6.5
18
35
JFB43
NOMESCO Finland
Left hemicolectomy
71.9
6.5
7
*
C49.19
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor
+∞
6.3
6
*
8850/3-C49.5
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of pelvis
+∞
6.3
6
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*
C49.99
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue other or unspecified tumor
+∞
6.3
6
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.7
6.2
20
46
A03FA01
ATC
metoclopramide; systemic, rectal
2.4
6.2
59
296
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
10.5
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
65
190
4.29
20.49
1.4
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
140
779
2.84
14.53
3.1
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
160
967
2.86
13.96
6.0
4.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
122
668
2.63
12.54
3.5
2.4
—
—
—
0
0
(3002256) Pathology report gross observation
64
255
3.04
12.07
1.8
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
95
513
2.38
9.47
3.6
2.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
36
123
3.26
8.66
9.3
8.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
76
394
2.34
8.13
4.1
3.1
mmol/l
2.5
2.5
0.17
63
348
(3023368) Bacteria identified in Blood by Culture
105
632
2.15
7.74
4.7
4.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
80
440
2.21
7.34
2.6
2.5
e6/l
5.0
3.7
0.61
69
391
(3024561) Albumin [Mass/volume] in Serum or Plasma
136
922
2.06
7.13
7.2
4.7
g/l
34.1
35.2
1.42
127
864
(36304419) Bacteria [Presence] in Urine
97
586
2.08
6.92
3.3
2.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
159
1159
2.04
6.62
14.4
10.2
e9/l
4.3
4.2
0.12
144
1018
(3002173) Hemoglobin [Mass/volume] in Arterial blood
49
229
2.42
6.50
9.0
7.9
g/l
118.6
121.9
0.60
49
222
(3003396) Base excess in Arterial blood by calculation
55
272
2.31
6.43
8.3
7.4
mmol/l
0.3
0.9
0.69
47
216
(3027801) Oxygen [Partial pressure] in Arterial blood
55
272
2.31
6.43
8.4
7.3
kpa
13.9
11.8
2.55
55
261
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
55
272
2.31
6.43
8.4
7.3
kpa
5.3
5.0
2.52
55
260
(3030467) Casts [#/volume] in Urine by Automated count
97
599
2.02
6.42
3.3
3.0
e6/l
0.6
0.4
0.19
72
445
(3032080) INR in Blood by Coagulation assay
131
909
1.94
6.10
11.7
8.4
inr
1.3
1.3
0.14
44
256
(3016502) Oxygen saturation in Arterial blood
50
249
2.26
5.71
8.7
7.6
%
97.7
95.5
4.94
50
239
(3000991) Gas panel - Venous blood
39
175
2.46
5.62
10.8
8.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
62
3.42
5.58
3.1
2.2
u/ml
0.3
0.4
0.38
12
32
(40758558) Short blood count panel - Blood
84
514
1.96
5.57
10.3
7.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
101
658
1.91
5.55
3.4
3.2
e6/l
24.1
174.9
0.89
76
509
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
35
151
2.54
5.48
3.7
2.9
ml/min/173m2
51.3
60.4
0.77
12
69
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
31
126
2.67
5.46
10.3
9.2
mmol/l
24.3
24.4
0.05
31
118
(3044889) 12 lead EKG panel
183
1452
2.00
5.41
4.6
4.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
139
1015
1.84
5.24
9.1
7.2
mmol/l
1.2
1.2
1.44
115
864
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
131
946
1.82
5.06
8.5
6.0
mmol/l
1.2
1.2
0.58
123
862
(3018095) Leukocytes [#/volume] in Urine
109
746
1.83
5.01
4.0
3.7
e6/l
50.0
80.7
0.46
81
541
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
44
221
2.21
4.90
5.1
3.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
195
1606
2.02
4.85
11.9
7.9
u/l
83.5
78.6
0.71
190
1512
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
227
1989
2.74
4.79
22.7
15.4
mg/l
34.5
24.8
3.41
207
1617
(3018418) pH of Serum or Plasma
93
619
1.81
4.60
6.4
4.1
ph
7.4
7.4
1.15
24
119
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
110
785
1.72
4.19
3.5
3.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
99
689
1.73
4.11
6.7
3.4
mmol/l
2.4
2.3
0.31
85
600
(3026782) Osmolality of Urine
68
425
1.83
4.07
2.8
2.8
mosm/kgh2o
529.9
576.8
1.06
54
365
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
31
147
2.27
3.95
1.2
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
43
242
1.94
3.52
3.6
4.7
ug/l
3.4
36.6
1.02
35
207
(3007853) Bacteria identified in Skin by Aerobe culture
43
244
1.92
3.44
1.9
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
117
885
1.61
3.36
13.2
10.3
e9/l
0.0
0.0
0.05
100
719
(3014111) Lactate [Moles/volume] in Serum or Plasma
36
194
2.00
3.33
9.3
6.7
mmol/l
1.0
1.4
1.94
36
188
(3012095) Magnesium [Moles/volume] in Serum or Plasma
55
342
1.78
3.30
3.6
3.2
mmol/l
0.8
0.8
0.17
55
323
(3042936) Bacteria identified in Isolate by Culture
51
313
1.79
3.19
2.0
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
30
158
2.02
2.96
6.5
3.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
68
464
1.64
2.89
3.8
3.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
124
975
1.55
2.87
4.2
3.7
estimate
0.0
0.0
0.00
30
187
(3003694) ABO and Rh group [Type] in Blood
75
527
1.61
2.83
1.3
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
56
368
1.67
2.74
2.8
2.6
e6/l
0.9
1.0
0.13
30
208
(3021601) Nitrite [Presence] in Urine by Test strip
123
975
1.52
2.69
5.3
5.0
estimate
0.0
0.0
0.00
28
188
(3019198) Lymphocytes [#/volume] in Blood
125
995
1.52
2.68
5.5
5.9
e9/l
2.3
1.8
0.40
108
872
(3013115) Eosinophils [#/volume] in Blood
126
1007
1.51
2.63
5.7
6.2
e9/l
0.2
0.2
0.10
109
883
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
11
5.56
2.56
4.2
4.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
12
275
0.41
2.50
3.3
4.8
%
30.5
31.1
—
6
181
(3006315) Basophils [#/volume] in Blood
122
981
1.48
2.41
5.5
5.8
e9/l
0.0
0.0
0.31
103
849
(3024928) Oxygen saturation in Venous blood
11
40
2.83
2.41
3.4
3.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
123
992
1.48
2.38
4.3
3.8
estimate
0.0
0.0
0.00
29
179
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
39
242
1.73
2.34
1.6
1.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
121
977
1.47
2.31
5.6
5.8
e9/l
0.6
0.6
0.28
103
839
(3020564) Creatinine [Moles/volume] in Serum or Plasma
229
2129
2.04
2.27
29.2
18.4
umol/l
85.0
81.4
0.89
229
2129
(3026008) Bacteria identified in Urine by Culture
77
573
1.50
2.19
3.1
3.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
39
248
1.68
2.15
1.7
1.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
46
307
1.61
2.11
2.5
2.3
g/l
2.2
2.3
0.86
46
282
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
20
3.57
2.07
1.1
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
20
3.57
2.07
1.3
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
51
353
1.56
2.01
3.1
2.8
e6/l
2.1
2.1
0.01
26
196
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
209
1909
1.62
1.99
23.9
14.2
ml/min/173m2
77.0
78.7
0.52
182
1577
(3047181) Lactate [Moles/volume] in Blood
13
59
2.27
1.87
6.4
7.1
mmol/l
1.4
1.3
0.12
13
53
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
18
94
1.99
1.85
6.2
3.5
mmol/l
22.9
24.1
0.83
18
83
(3009542) Hematocrit [Volume Fraction] of Blood
195
1763
1.50
1.85
27.1
16.3
%
38.2
39.9
1.52
144
1213
(3025941) Bacteria identified in Stool by Culture
19
102
1.93
1.82
1.1
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
157
1366
1.41
1.82
4.4
4.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
85
666
1.42
1.81
6.0
5.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
233
2206
1.99
1.75
35.2
22.5
e9/l
253.6
240.2
2.13
227
2140
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
13
61
2.19
1.75
1.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
223
2086
1.71
1.73
20.8
14.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
47
0.00
1.72
0.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
13
3.90
1.72
1.2
1.9
%
11.1
11.5
—
5
13
(3010813) Leukocytes [#/volume] in Blood
233
2208
1.97
1.71
35.2
22.6
e9/l
7.3
6.7
1.03
226
2134
(3026361) Erythrocytes [#/volume] in Blood
233
2208
1.97
1.71
35.1
22.5
e12/l
4.4
4.5
2.21
226
2134
(3012544) pH of Venous blood
30
191
1.65
1.67
5.1
3.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
72
556
1.42
1.65
5.0
3.9
estimate
0.0
0.0
0.00
30
180
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
227
2139
1.76
1.63
14.8
11.0
u/l
28.1
26.7
0.51
218
2057
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
14
3.62
1.62
1.8
2.3
—
—
—
0
0
(3035880) pH of Pleural fluid
5
14
3.62
1.62
1.2
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
55
407
1.45
1.58
4.1
5.0
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
5
15
3.38
1.53
1.0
1.7
u/l
13.4
14.8
—
5
15
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
94
769
1.36
1.51
4.5
3.9
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
24
149
1.68
1.47
7.8
7.3
mmol/l
24.6
24.0
0.60
24
140
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
56
422
1.42
1.46
4.2
3.5
ng/l
66.3
239.5
1.24
49
352
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
16
3.17
1.44
2.6
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
22
2.77
1.44
2.3
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
38
267
1.50
1.41
1.3
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
28
184
1.59
1.39
4.7
3.7
mmol/l
0.8
1.9
1.21
23
135
(3016879) Cocaine [Presence] in Urine
0
37
0.00
1.35
0.0
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
38
0.00
1.35
0.0
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
39
0.00
1.35
0.0
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
0
39
0.00
1.35
0.0
1.6
—
204.6
—
0
19
(3028300) Cannabinoids [Presence] in Urine
0
39
0.00
1.35
0.0
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
39
0.00
1.35
0.0
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
9
43
2.13
1.31
1.6
2.6
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
6
24
2.54
1.31
1.0
1.4
u/l
237.8
251.4
—
6
24
(3002030) Lymphocytes/100 leukocytes in Blood
109
928
1.31
1.30
6.3
6.1
%
25.7
26.4
0.18
104
868
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
55
2.05
1.29
1.5
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
55
2.05
1.29
1.3
1.3
—
—
—
0
0
(4306422)
6
25
2.43
1.25
1.0
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
25
2.43
1.25
1.2
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
12
63
1.95
1.25
2.2
3.8
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
104
884
1.30
1.24
6.1
6.0
%
0.6
0.7
0.32
99
829
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
47
354
1.40
1.23
1.7
1.8
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
5
19
2.66
1.22
1.0
1.3
u/l
15.2
10.1
—
5
19
(3006504) Eosinophils/100 leukocytes in Blood
106
905
1.30
1.22
6.3
6.0
%
2.5
2.8
0.63
101
846
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
15
86
1.79
1.22
4.1
2.1
ug/l
358.5
796.1
0.39
15
80
(3018677) aPTT in Platelet poor plasma by Coagulation assay
46
346
1.40
1.21
4.5
2.1
s
31.6
29.3
1.85
46
331
(1002224) Polysomnography panel
14
79
1.82
1.19
1.1
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
33
0.00
1.17
0.0
2.3
—
34.7
—
0
9
(3019069) Monocytes/100 leukocytes in Blood
106
909
1.29
1.17
6.7
6.2
%
9.2
8.9
0.32
101
857
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
20
2.53
1.15
1.8
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
30
2.37
1.13
4.7
2.1
e9/l
4.4
4.8
—
7
30
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
30
2.37
1.13
2.4
1.7
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
31
2.29
1.11
1.4
1.9
%
60.4
63.6
—
7
31
(3036489) Thrombin time
12
66
1.86
1.11
3.3
2.0
s
22.9
22.4
0.13
12
57
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
21
2.41
1.09
1.8
3.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
32
2.22
1.09
5.9
2.9
%
62.6
61.1
—
7
32
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
8
148
0.53
1.07
2.3
3.5
kpa
5.0
5.0
—
8
136
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
22
2.30
1.04
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
22
2.30
1.04
1.2
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
34
2.09
1.03
1.3
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
34
2.09
1.03
1.3
1.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
105
911
1.27
1.03
6.1
5.9
%
58.7
58.1
0.19
99
859
(3018572) Chloride [Moles/volume] in Blood
9
49
1.87
0.99
7.7
6.5
mmol/l
107.3
105.1
—
9
44
(3039000) Anion gap in Blood
9
49
1.87
0.99
7.6
6.5
mmol/l
10.1
11.6
—
9
44
(3011412) CD3 cells [#/volume] in Blood
5
23
2.20
0.98
1.8
2.0
e9/l
0.7
1.1
—
5
10
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
23
2.20
0.98
1.0
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
34
253
1.40
0.97
3.5
4.4
u/l
198.9
242.5
4.32
34
241
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
32
0.00
0.96
0.0
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
63
517
1.29
0.95
2.2
2.0
mg/l
2.8
3.3
0.81
55
452
(3022217) INR in Platelet poor plasma by Coagulation assay
40
307
1.36
0.95
28.6
23.0
inr
1.5
1.3
—
6
34
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
37
1.92
0.95
3.3
2.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
10
55
1.85
0.93
1.1
1.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
86
1.67
0.93
2.8
1.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
23
160
1.48
0.93
5.4
4.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
28
2.17
0.92
1.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
44
1.84
0.86
1.9
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
46
1.76
0.83
1.0
1.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
25
183
1.41
0.79
6.9
6.6
mmol/l
11.2
9.8
0.40
25
174
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
48
1.69
0.79
1.3
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
26
0.00
0.79
0.0
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
28
0.00
0.76
0.0
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
53
1.72
0.76
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
9
53
1.72
0.76
1.1
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
9
53
1.72
0.76
3.0
2.5
mg/l
1.8
1.7
—
9
47
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
53
1.72
0.76
1.1
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
161
1496
1.22
0.75
3.3
4.1
mm/h
13.0
12.5
0.17
145
1368
(4268621)
5
24
2.10
0.75
2.0
1.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
24
2.10
0.75
1.0
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
55
1.66
0.74
1.3
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
39
1.82
0.73
2.4
1.8
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
5
25
2.02
0.73
3.4
1.4
%
88.1
88.9
—
5
25
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
5
26
1.94
0.71
1.0
1.2
—
1.4
—
0
8
(3023419) Bacteria identified in Sputum by Culture
5
29
1.74
0.64
1.2
3.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
29
1.74
0.64
1.2
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
53
449
1.23
0.62
2.0
1.7
mg/l
1.2
1.4
0.37
43
364
(3026493) Urate [Moles/volume] in Serum or Plasma
65
564
1.21
0.61
2.8
2.8
umol/l
387.8
7331.5
2.61
56
476
(3028707) Methadone [Presence] in Urine by Screen method
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
20
0.00
0.60
0.0
2.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
78
876
0.84
0.60
3.6
4.0
ng/l
49.7
43.4
0.16
65
654
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
141
1310
1.18
0.60
2.8
3.1
u/l
71.5
52.6
0.53
132
1229
(4146454)
0
22
0.00
0.59
0.0
3.0
—
—
—
0
0
(3010421) pH of Blood
8
53
1.53
0.59
3.0
2.3
ph
7.4
7.4
—
8
44
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
53
1.53
0.59
2.3
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
35
1.73
0.58
2.3
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
37
1.64
0.56
2.3
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
9
62
1.47
0.53
1.3
1.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
6
96
0.62
0.53
2.0
2.0
ug/l
0.2
5.6
—
6
90
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
187
1789
1.19
0.52
4.1
4.4
mu/l
1.9
2.0
0.59
165
1607
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
40
1.51
0.52
2.3
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
65
1.40
0.51
1.7
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
150
1415
1.15
0.48
3.5
3.6
pmol/l
15.0
14.9
0.10
132
1260
(40768443) Skin Pathology biopsy report
12
85
1.43
0.48
1.6
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
38
446
0.83
0.47
1.8
1.8
pmol/l
225000380.2
446.8
0.49
32
372
(3007930) Methemoglobin/Hemoglobin.total in Blood
12
86
1.42
0.45
6.9
5.5
%
1.1
0.9
0.97
12
80
(3000492) Spirometry study
24
194
1.26
0.44
1.5
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
78
1.43
0.44
1.8
2.9
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
47
536
0.85
0.43
1.7
1.7
mmol/l
1.6
1.4
0.59
34
447
(3024980) IgG subclass 4 [Mass/volume] in Serum
5
31
1.63
0.43
1.0
2.3
g/l
0.6
1.2
—
5
24
(3020891) Body temperature
12
87
1.40
0.43
4.8
4.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
20
159
1.28
0.41
2.7
4.7
%
0.0
0.2
—
10
59
(3043409) Potassium [Moles/volume] in Arterial blood
11
79
1.41
0.41
4.8
3.9
mmol/l
3.8
3.9
0.72
11
72
(3017704) Immunofixation for Urine
0
15
0.00
0.41
0.0
2.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
17
0.00
0.41
0.0
1.3
—
12.2
—
0
6
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
105
0.66
0.40
1.4
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
9
67
1.36
0.38
1.1
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
23
189
1.24
0.37
1.8
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
37
1.36
0.37
1.6
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
50
444
1.16
0.37
4.3
4.0
kg/l
1.0
1.0
—
10
66
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
12
90
1.35
0.36
6.9
5.4
%
1.9
1.6
0.61
12
84
(3017181) Myelocytes/100 leukocytes in Blood
21
172
1.24
0.35
2.9
4.6
%
0.9
0.9
—
10
66
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
45
1.34
0.34
2.3
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
86
0.69
0.33
1.7
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
17
137
1.26
0.33
1.3
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
34
388
0.86
0.32
1.2
1.2
u/ml
0.7
1.9
—
8
108
(3041096) Erythrocytes [Presence] in Urine by Automated
59
536
1.13
0.32
4.3
3.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
53
1.33
0.31
2.4
1.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
70
646
1.12
0.30
2.9
3.3
mg/l
476.9
244.2
0.21
50
446
(3022145) Colonoscopy Study observation
28
242
1.18
0.29
1.4
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
33
374
0.86
0.29
2.0
1.4
g/l
2.3
2.7
0.74
21
226
(3019225) pH of Specimen
17
204
0.82
0.28
4.4
4.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
31
273
1.15
0.26
12.2
7.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
33
293
1.15
0.25
1.2
1.3
—
—
—
0
0
(3013512) EKG study
60
648
0.90
0.25
3.5
4.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
105
1.25
0.25
1.3
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
30
265
1.15
0.25
1.5
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
18
153
1.19
0.23
2.9
4.7
%
0.6
0.4
—
7
49
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
39
1.29
0.23
1.0
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
27
304
0.87
0.22
1.3
1.2
u/ml
7.1
13.3
—
10
117
(3021901) Oxygen saturation in Capillary blood
5
41
1.22
0.22
1.6
2.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
42
1.19
0.21
1.8
2.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
8
101
0.79
0.21
2.3
4.3
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
7.5
—
0.6
—
0
11
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
9.5
—
0
10
(3032773) Endomysium IgG Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
71
668
1.09
0.21
2.9
3.2
mmol/l
7.2
7.9
0.60
60
563
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.7
—
868.5
—
0
13
(3028626) Oxygen [Partial pressure] in Capillary blood
6
48
1.26
0.20
2.2
2.3
kpa
8.0
8.1
—
6
43
(3017143) Hepatitis C virus Ab [Presence] in Serum
22
193
1.15
0.20
1.2
1.6
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.4
—
0.1
—
0
9
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
0
14
0.00
0.20
0.0
7.9
—
7.4
—
0
5
(3019309) Folate [Moles/volume] in Red Blood Cells
37
404
0.90
0.19
1.8
1.7
nmol/l
1100.6
1212.7
0.22
28
309
(3049717) Cytology report of Urine Cyto stain
12
100
1.21
0.18
3.0
3.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
121
0.82
0.18
1.5
1.8
—
—
—
0
0
(4094501)
7
62
1.13
0.17
1.0
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
68
644
1.08
0.17
3.3
2.1
u/l
156.9
342.7
0.93
68
607
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
24
215
1.13
0.17
1.2
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
81
773
1.07
0.17
2.2
2.3
nmol/l
74.0
76.7
0.42
75
678
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
16
139
1.16
0.16
1.3
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
13
151
0.85
0.16
1.2
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
17
149
1.15
0.16
3.0
4.8
%
0.1
0.2
—
8
51
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
78
0.76
0.16
1.7
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
21
188
1.13
0.15
1.3
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
85
816
1.06
0.15
4.4
4.5
%
21.8
21.0
0.18
39
398
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
88
0.79
0.15
1.1
1.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
14
122
1.16
0.14
1.0
1.2
—
49.5
—
0
10
(3019832) Treponema pallidum Ab [Presence] in Serum
8
97
0.82
0.14
1.0
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
12
138
0.86
0.13
3.1
2.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
20
181
1.11
0.12
4.5
3.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
116
0.86
0.12
1.0
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
86
1.17
0.11
1.2
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
194
1964
0.94
0.11
4.7
4.9
mmol/l
6.3
6.1
1.18
173
1790
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
35
329
1.07
0.11
1.2
1.2
iu/ml
45.6
33.0
0.19
14
105
(3021879) Hepatitis B virus core Ab [Presence] in Serum
14
125
1.13
0.10
1.2
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
55
1.09
0.09
1.2
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
61
589
1.05
0.08
2.9
3.0
ug/l
0.6
0.8
1.15
47
396
(3021960) Folate [Moles/volume] in Serum or Plasma
52
501
1.05
0.08
1.5
1.6
nmol/l
20.5
20.4
0.01
47
417
(3034860) Kappa light chains.free [Mass/volume] in Serum
6
71
0.84
0.07
2.5
5.1
mg/l
33.7
144.9
—
6
53
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
6
71
0.84
0.07
2.5
5.1
mg/l
27.5
33.7
—
6
55
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
197
1988
0.96
0.07
4.1
4.7
mmol/l
4.6
4.5
0.18
180
1826
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
73
712
1.04
0.06
3.3
3.1
ng/l
2008.2
1265.1
0.78
67
611
(36660697) Celiac disease serology panel - Serum
15
139
1.08
0.05
1.1
1.1
—
—
—
0
0
(4010399)
17
159
1.07
0.05
1.1
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
120
0.91
0.05
1.5
2.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
192
1907
1.03
0.04
5.6
6.2
mmol/mol
40.6
40.6
0.00
174
1772
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
110
1112
0.98
0.03
2.8
2.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
204
2030
1.03
0.03
4.7
5.3
mmol/l
2.7
2.7
0.37
186
1847
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
197
1980
0.98
0.02
4.0
4.7
mmol/l
1.4
1.4
1.56
178
1800
(21494755) Public health laboratory ask at order entry panel
13
137
0.95
0.01
1.4
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
103
1023
1.01
0.01
5.0
5.1
ug/l
2.2
2.6
0.28
91
915
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
106
0.94
0.01
1.5
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
69
684
1.01
0.00
3.6
4.0
mg/mmol
5.5
8.4
0.41
48
457
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
14
141
0.99
0.00
1.8
2.4
—
12.8
—
0
9
(1761868) Lipid panel - Serum or Plasma
69
689
1.00
0.00
2.8
3.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
191
1912
1.00
0.00
3.6
4.2
mmol/l
1.4
1.3
0.96
169
1732
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
83
828
1.00
0.00
1.9
2.0
pmol/l
92.7
94.2
0.11
45
437
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
10
96
1.04
0.00
2.0
2.2
u/l
31.1
39.9
—
10
87
(46235355) HIV 1 and 2 tests - Meaningful Use set
26
256
1.02
0.00
1.4
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
19
195
0.97
0.00
2.3
2.7
e9/l
62.2
68.1
0.34
12
156
(3004588) Protein electrophoresis panel - Serum or Plasma
15
155
0.97
0.00
2.5
2.7
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
6
60
1.00
0.00
1.2
1.2
—
3.0
—
0
6
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.5
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(4034850)
8
79
1.01
0.00
7.2
12.5
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
54
0.92
0.00
2.2
6.0
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
7
69
1.01
0.00
2.3
1.6
nmol/l
39.1
45.9
—
7
64
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.7
—
8.2
—
0
9
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
7
79
0.88
0.00
1.7
1.8
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
4.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
1.1
—
0
5
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
9
0.00
0.00
0.0
1.2
—
6.3
—
0
9
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.2
—
1.2
—
0
5
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
4.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
59
1.02
0.00
1.3
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
61
0.98
0.00
1.5
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
7
0.00
0.00
0.0
1.0
—
21.3
—
0
7
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_LIPOSARCOMA – Liposarcoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).